| 4.3 |
21.3 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 4.1 |
12.2 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 3.7 |
14.9 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 3.6 |
14.5 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 3.1 |
12.4 |
GO:0097393 |
post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 2.9 |
8.8 |
GO:1990481 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) snRNA pseudouridine synthesis(GO:0031120) mRNA pseudouridine synthesis(GO:1990481) |
| 2.9 |
11.7 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 2.4 |
14.7 |
GO:0051660 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) |
| 2.1 |
6.2 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 2.0 |
18.0 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 2.0 |
10.0 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 2.0 |
3.9 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 1.9 |
9.5 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 1.9 |
5.6 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 1.8 |
9.1 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 1.8 |
9.0 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 1.8 |
9.0 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 1.8 |
26.8 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 1.7 |
5.0 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 1.6 |
6.6 |
GO:0019042 |
viral latency(GO:0019042) |
| 1.6 |
12.9 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 1.6 |
6.3 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 1.6 |
12.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 1.5 |
6.1 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 1.5 |
8.9 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 1.5 |
1.5 |
GO:0034183 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 1.5 |
4.4 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 1.5 |
8.7 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 1.5 |
2.9 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 1.5 |
4.4 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 1.4 |
2.9 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 1.4 |
4.3 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 1.4 |
5.7 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 1.4 |
4.2 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.4 |
5.6 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 1.4 |
8.3 |
GO:0035372 |
protein localization to microtubule(GO:0035372) mitotic cytokinetic process(GO:1902410) |
| 1.4 |
5.5 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 1.3 |
5.0 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 1.3 |
12.6 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 1.2 |
3.7 |
GO:0032240 |
RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 1.2 |
3.7 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) protein K29-linked ubiquitination(GO:0035519) |
| 1.2 |
2.4 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 1.2 |
4.8 |
GO:0097709 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
| 1.2 |
4.6 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 1.2 |
4.6 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 1.1 |
3.4 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.1 |
3.4 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 1.1 |
11.3 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 1.1 |
2.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 1.1 |
4.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 1.1 |
6.7 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 1.1 |
14.5 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 1.1 |
7.8 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 1.1 |
4.4 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 1.1 |
5.5 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 1.1 |
3.3 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 1.1 |
3.3 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 1.1 |
4.3 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 1.1 |
3.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.1 |
10.8 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 1.1 |
4.3 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 1.1 |
6.4 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 1.0 |
3.1 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 1.0 |
8.4 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 1.0 |
1.0 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 1.0 |
4.2 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 1.0 |
13.5 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 1.0 |
4.1 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 1.0 |
3.1 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 1.0 |
3.1 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.0 |
2.0 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 1.0 |
5.1 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 1.0 |
3.0 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 1.0 |
6.0 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 1.0 |
2.9 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.0 |
12.7 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 1.0 |
2.9 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.0 |
3.9 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.9 |
4.7 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.9 |
3.8 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.9 |
1.9 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.9 |
1.9 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.9 |
1.9 |
GO:0061738 |
late endosomal microautophagy(GO:0061738) |
| 0.9 |
4.6 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.9 |
0.9 |
GO:0045738 |
negative regulation of DNA repair(GO:0045738) |
| 0.9 |
2.8 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.9 |
3.7 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.9 |
12.8 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.9 |
5.4 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.9 |
5.4 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.9 |
4.5 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.9 |
2.6 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.9 |
3.5 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.9 |
10.4 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.9 |
3.4 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.9 |
1.7 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.8 |
2.5 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.8 |
2.5 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.8 |
5.0 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.8 |
2.5 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.8 |
0.8 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.8 |
1.6 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.8 |
4.9 |
GO:0070989 |
oxidative demethylation(GO:0070989) |
| 0.8 |
6.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.8 |
3.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.8 |
2.4 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.8 |
9.6 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.8 |
4.0 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.8 |
1.6 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.8 |
2.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.8 |
3.9 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.8 |
6.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.8 |
3.9 |
GO:0071038 |
nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
| 0.8 |
10.6 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.8 |
2.3 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.7 |
8.2 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.7 |
5.9 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.7 |
2.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.7 |
3.7 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.7 |
3.6 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.7 |
5.0 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.7 |
5.7 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.7 |
2.8 |
GO:0090169 |
regulation of spindle assembly(GO:0090169) |
| 0.7 |
4.9 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.7 |
2.1 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.7 |
3.5 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.7 |
2.1 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.7 |
6.9 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.7 |
2.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.7 |
3.4 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.7 |
3.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.7 |
3.4 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.7 |
7.4 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.7 |
0.7 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.7 |
9.3 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.7 |
2.0 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.7 |
3.3 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.7 |
2.0 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.6 |
2.6 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.6 |
2.6 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.6 |
3.2 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.6 |
3.8 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.6 |
7.5 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.6 |
5.6 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.6 |
9.8 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.6 |
2.5 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.6 |
3.1 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.6 |
5.5 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.6 |
2.4 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.6 |
2.4 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.6 |
3.0 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.6 |
4.2 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.6 |
1.8 |
GO:0060729 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) replication fork protection(GO:0048478) intestinal epithelial structure maintenance(GO:0060729) |
| 0.6 |
10.1 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.6 |
14.7 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.6 |
1.8 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.6 |
4.7 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.6 |
4.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.6 |
1.7 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.6 |
1.7 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.6 |
1.1 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.6 |
3.4 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.6 |
4.5 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.6 |
6.6 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.5 |
2.7 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 0.5 |
1.6 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.5 |
4.9 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.5 |
1.1 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.5 |
3.7 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.5 |
2.1 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.5 |
3.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.5 |
2.7 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.5 |
1.1 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.5 |
14.1 |
GO:0031571 |
mitotic G1 DNA damage checkpoint(GO:0031571) |
| 0.5 |
3.1 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.5 |
3.6 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.5 |
1.5 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.5 |
3.6 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.5 |
4.6 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.5 |
1.0 |
GO:1904683 |
regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.5 |
18.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.5 |
4.0 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.5 |
3.9 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
| 0.5 |
4.8 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.5 |
5.3 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.5 |
3.3 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.5 |
1.4 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.5 |
1.8 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.5 |
4.5 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.5 |
1.8 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.5 |
1.8 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.4 |
1.8 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.4 |
1.8 |
GO:1901563 |
response to camptothecin(GO:1901563) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.4 |
1.8 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.4 |
8.7 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.4 |
11.7 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.4 |
15.2 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.4 |
3.0 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.4 |
25.1 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.4 |
10.3 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.4 |
2.0 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.4 |
2.4 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.4 |
3.2 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.4 |
2.0 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.4 |
7.2 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.4 |
6.0 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.4 |
10.3 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.4 |
2.4 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 0.4 |
0.8 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 |
1.2 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.4 |
3.5 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.4 |
5.8 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.4 |
1.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.4 |
7.0 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.4 |
8.5 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.4 |
2.3 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) paranodal junction assembly(GO:0030913) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.4 |
1.9 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.4 |
2.2 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.4 |
2.2 |
GO:1902715 |
positive regulation of interleukin-2 secretion(GO:1900042) positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.4 |
1.9 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) negative regulation of trophoblast cell migration(GO:1901164) |
| 0.4 |
3.3 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.4 |
2.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.4 |
2.6 |
GO:0039529 |
RIG-I signaling pathway(GO:0039529) |
| 0.4 |
1.5 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.4 |
1.1 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.4 |
2.1 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.4 |
2.1 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.4 |
3.2 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.3 |
2.8 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.3 |
6.6 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.3 |
1.0 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.3 |
2.4 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.3 |
1.0 |
GO:0097278 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) complement-dependent cytotoxicity(GO:0097278) |
| 0.3 |
3.7 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.3 |
2.7 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.3 |
2.7 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.3 |
3.0 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.3 |
1.7 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 |
1.0 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.3 |
6.6 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.3 |
1.3 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.3 |
1.0 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.3 |
3.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.3 |
2.6 |
GO:0000479 |
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.3 |
1.0 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.3 |
0.6 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.3 |
1.0 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 |
1.6 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) response to pheromone(GO:0019236) |
| 0.3 |
6.9 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.3 |
0.3 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.3 |
43.7 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
| 0.3 |
1.2 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.3 |
37.0 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.3 |
1.5 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.3 |
0.9 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.3 |
2.4 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.3 |
1.8 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.3 |
14.7 |
GO:0006405 |
RNA export from nucleus(GO:0006405) |
| 0.3 |
4.2 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.3 |
3.5 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.3 |
1.8 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.3 |
2.3 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.3 |
6.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.3 |
2.6 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.3 |
0.6 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.3 |
4.3 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.3 |
1.4 |
GO:0044828 |
negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.3 |
0.9 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.3 |
0.9 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.3 |
1.4 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.3 |
3.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 |
2.5 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.3 |
0.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.3 |
11.3 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.3 |
4.0 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.3 |
1.0 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
| 0.3 |
3.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.3 |
2.1 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.3 |
1.0 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.3 |
1.0 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 |
2.0 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 |
0.5 |
GO:0009838 |
abscission(GO:0009838) |
| 0.3 |
1.5 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.3 |
1.0 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.3 |
3.5 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.3 |
3.5 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.3 |
2.5 |
GO:2000637 |
positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.2 |
7.0 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.2 |
4.2 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.2 |
1.0 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
0.7 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.2 |
0.7 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
3.2 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.2 |
2.2 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.2 |
2.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 |
1.7 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.2 |
2.6 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.2 |
4.7 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.2 |
1.4 |
GO:0051461 |
corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 |
2.1 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.2 |
0.7 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.2 |
1.6 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 |
9.0 |
GO:0017145 |
stem cell division(GO:0017145) |
| 0.2 |
3.4 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.2 |
2.3 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 |
1.6 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.2 |
3.4 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 |
3.6 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.2 |
4.9 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 |
2.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 |
2.0 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 |
3.3 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.2 |
1.1 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.2 |
1.5 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 |
1.5 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.2 |
0.9 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.2 |
0.4 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.2 |
1.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 |
2.2 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.2 |
8.9 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.2 |
1.7 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.2 |
0.4 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.2 |
2.1 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.2 |
1.3 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.2 |
0.6 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.2 |
0.8 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.2 |
1.8 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.2 |
0.8 |
GO:1903912 |
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.2 |
2.2 |
GO:0035196 |
production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
| 0.2 |
3.4 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.2 |
1.0 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.2 |
10.7 |
GO:0006397 |
mRNA processing(GO:0006397) |
| 0.2 |
0.6 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.2 |
0.2 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
4.0 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.2 |
0.9 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.2 |
0.6 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
4.8 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.2 |
1.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.2 |
2.0 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.2 |
2.0 |
GO:0002176 |
male germ cell proliferation(GO:0002176) |
| 0.2 |
4.6 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.2 |
3.8 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.2 |
5.2 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.2 |
1.2 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.2 |
0.5 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.2 |
0.7 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.2 |
0.7 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.2 |
1.2 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.2 |
0.7 |
GO:1904008 |
cellular response to salt(GO:1902075) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.2 |
0.3 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.2 |
5.4 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.2 |
1.0 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
0.2 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.2 |
1.1 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.2 |
3.1 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.2 |
0.8 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.2 |
3.3 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.2 |
2.7 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.2 |
0.8 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.2 |
0.5 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.2 |
2.0 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.2 |
0.3 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 |
0.8 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.2 |
1.7 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.2 |
1.1 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 |
2.4 |
GO:0031663 |
lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.1 |
6.4 |
GO:0002224 |
toll-like receptor signaling pathway(GO:0002224) |
| 0.1 |
1.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
1.5 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
0.9 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 |
1.3 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.9 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
3.8 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.7 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.1 |
5.2 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.1 |
3.0 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.1 |
1.0 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
2.2 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) positive regulation of behavior(GO:0048520) |
| 0.1 |
0.6 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
1.1 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.1 |
1.2 |
GO:0048863 |
stem cell differentiation(GO:0048863) |
| 0.1 |
0.5 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
3.5 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.1 |
1.1 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
1.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
2.3 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.1 |
5.0 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.1 |
0.4 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) vitamin K metabolic process(GO:0042373) |
| 0.1 |
12.4 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.1 |
0.4 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
1.0 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.4 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 |
1.6 |
GO:0032272 |
negative regulation of protein polymerization(GO:0032272) |
| 0.1 |
2.0 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.1 |
0.3 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.7 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.1 |
0.8 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.1 |
0.4 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
0.2 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.1 |
0.4 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.1 |
0.5 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 |
2.7 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.7 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
4.9 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.1 |
1.4 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
2.2 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.1 |
1.5 |
GO:0006260 |
DNA replication(GO:0006260) |
| 0.1 |
0.5 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
0.7 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
2.2 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.1 |
3.2 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.1 |
0.3 |
GO:0048341 |
paraxial mesoderm morphogenesis(GO:0048340) paraxial mesoderm formation(GO:0048341) |
| 0.1 |
1.1 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.8 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.1 |
0.6 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.1 |
0.6 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 |
2.4 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
1.0 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.1 |
1.9 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.1 |
2.8 |
GO:0060395 |
SMAD protein signal transduction(GO:0060395) |
| 0.1 |
2.1 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 |
2.0 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
1.0 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.1 |
1.3 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.1 |
1.2 |
GO:0016568 |
chromatin modification(GO:0016568) |
| 0.1 |
0.3 |
GO:0010869 |
regulation of receptor biosynthetic process(GO:0010869) |
| 0.1 |
0.2 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.2 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
1.7 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.1 |
0.7 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.1 |
0.4 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.1 |
0.6 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.1 |
2.0 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.1 |
0.8 |
GO:0021924 |
cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.1 |
1.5 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
1.2 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.1 |
0.6 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
1.0 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 |
0.5 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.1 |
3.3 |
GO:0043507 |
positive regulation of JUN kinase activity(GO:0043507) |
| 0.1 |
3.1 |
GO:0032330 |
regulation of chondrocyte differentiation(GO:0032330) |
| 0.1 |
0.8 |
GO:0042113 |
B cell activation(GO:0042113) |
| 0.1 |
1.8 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.1 |
1.0 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.9 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.1 |
0.1 |
GO:0042795 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
1.3 |
GO:0032760 |
positive regulation of tumor necrosis factor production(GO:0032760) |
| 0.1 |
0.5 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.1 |
0.6 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.1 |
0.6 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.1 |
2.4 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
0.5 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
0.2 |
GO:0018022 |
peptidyl-lysine methylation(GO:0018022) |
| 0.1 |
1.0 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.3 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.1 |
2.4 |
GO:0045740 |
positive regulation of DNA replication(GO:0045740) |
| 0.1 |
3.3 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
0.9 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.1 |
1.0 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 |
3.4 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.1 |
0.2 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
5.3 |
GO:0006399 |
tRNA metabolic process(GO:0006399) |
| 0.1 |
1.5 |
GO:0046785 |
microtubule polymerization(GO:0046785) |
| 0.1 |
2.3 |
GO:0001935 |
endothelial cell proliferation(GO:0001935) |
| 0.1 |
1.7 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.1 |
0.2 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.1 |
0.6 |
GO:0045930 |
negative regulation of mitotic cell cycle(GO:0045930) |
| 0.1 |
3.0 |
GO:0006974 |
cellular response to DNA damage stimulus(GO:0006974) |
| 0.1 |
0.9 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.1 |
0.3 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
0.8 |
GO:0006352 |
DNA-templated transcription, initiation(GO:0006352) |
| 0.1 |
1.5 |
GO:0035315 |
hair cell differentiation(GO:0035315) auditory receptor cell differentiation(GO:0042491) |
| 0.1 |
0.3 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 |
1.7 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.1 |
1.0 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.6 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
0.6 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.9 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.2 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
2.8 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.4 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
5.8 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.0 |
1.0 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.6 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.6 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
1.1 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.9 |
GO:0060828 |
regulation of canonical Wnt signaling pathway(GO:0060828) |
| 0.0 |
3.6 |
GO:0006396 |
RNA processing(GO:0006396) |
| 0.0 |
2.2 |
GO:0021954 |
central nervous system neuron development(GO:0021954) |
| 0.0 |
2.5 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
1.2 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
2.7 |
GO:1902652 |
cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
| 0.0 |
0.1 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.0 |
1.1 |
GO:0071897 |
DNA biosynthetic process(GO:0071897) |
| 0.0 |
2.2 |
GO:0030326 |
embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
| 0.0 |
0.8 |
GO:0008584 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.0 |
0.2 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.0 |
2.1 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.0 |
0.4 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.0 |
0.3 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.7 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
3.0 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
1.0 |
GO:0071456 |
cellular response to hypoxia(GO:0071456) |
| 0.0 |
0.5 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.0 |
0.2 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.0 |
4.6 |
GO:0006281 |
DNA repair(GO:0006281) |
| 0.0 |
0.6 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
3.8 |
GO:0007067 |
mitotic nuclear division(GO:0007067) |
| 0.0 |
0.1 |
GO:0072595 |
maintenance of protein localization in organelle(GO:0072595) |
| 0.0 |
0.2 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 |
0.4 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.3 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.4 |
GO:0001824 |
blastocyst development(GO:0001824) |
| 0.0 |
0.1 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.3 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.0 |
1.9 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
| 0.0 |
1.2 |
GO:0006913 |
nucleocytoplasmic transport(GO:0006913) |
